Cefoperazone Sulbactam

CEPOVIB S

COMPOSITION
Cefoperazone500MG | 1000MG
Sulbactam500MG | 500MG
SPECIFICATION
FORMINJECTABLE
PACKING 1’s
PACKING TYPE
MRP199 | 285

DESCRIPTION

Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.
Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys antibiotic activity.

SIDE EFFECTS

Symptoms of overdose include blood in the urine, diarrhea, nausea, upper abdominal pain, and vomiting.
N/A

INDICATION

For the treatment of bacterial infections caused by susceptible microorganisms.
“Sulbactam is currently available in combination products with ampicillin. Within this formulation it is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli, Klebsiella spp. (including K. pneumoniae), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and Acinetobacter calcoaceticus.
Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. pneumoniae), Bacteroides spp. (including B. fragilis), and Enterobacter spp.
Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).”